PRETERM LABOUR. Preterm labour without delivery
Conditions
Interventions
Intervention 1: Intervention group: intramuscular dose of 250 mg 17 - alpha-hydroxyprogesterone caproate is administered once a week until the occurrence of preterm birth or complete of 34 weeks of pr
Treatment - Drugs
Intervention group: intramuscular dose of 250 mg 17 - alpha-hydroxyprogesterone caproate is administered once a week until the occurrence of preterm birth or complete of 34 weeks of pregnancy
Control group: intramuscular dose of 250 mg placebo injection is administered once a week until the occurrence of preterm birth or complete of 34 weeks of pregnancy
Sponsors
Kurdestan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: single gestation; history of preterm labour before 37 week; history of preterm birth; history of preterm labour in sister;congenital or acquired uterine anomalies; age>18 and 45; IUGR; vaginal bleeding; PROM; cervical dilation>2cm; fetal major anomalies; progesterone sensitivity; not to follow up the patients; twin pregnancy; tocolytic contraindications; uterine contraction; diabetes; history of cerclage; shortening of cervix.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Preterm labour before of 37 weeks. Timepoint: At the onset of intervention to preterm labor or to complete 37 weeks of pregnancy. Method of measurement: Patient visits, uterine contraction determination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNazli Hamrah MD
Besat Hospital
Outcome results
None listed